๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action

โœ Scribed by R. Gold; R.A. Linker; M. Stangel


Book ID
113541963
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
170 KB
Volume
142
Category
Article
ISSN
1090-2341

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Oral fumaric acid esters for the treatme
โœ S. Schimrigk; N. Brune; K. Hellwig; C. Lukas; B. Bellenberg; M. Rieks; V. Hoffma ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB

An exploratory, prospective, openโ€label study of fumaric acid esters (FAE, Fumadermยฎ) was conducted in patients with relapsingโ€“remitting multiple sclerosis (RRMS). The study consisted of the following four phases: 6โ€week baseline, 18โ€week treatment (target dose of 720โ€ƒmg/day), 4โ€week washout, and a